Published in J Biol Chem on June 22, 2004
Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Microbiol Mol Biol Rev (2012) 1.92
Bioinformatics analysis of the locus for enterocyte effacement provides novel insights into type-III secretion. BMC Microbiol (2005) 1.78
IpaB-IpgC interaction defines binding motif for type III secretion translocator. Proc Natl Acad Sci U S A (2009) 1.37
Control of gene expression by type III secretory activity. Curr Opin Microbiol (2008) 1.36
CLPM: a cross-linked peptide mapping algorithm for mass spectrometric analysis. BMC Bioinformatics (2005) 1.08
Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice. Vaccine (2008) 0.89
YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis. J Biol Chem (2010) 0.88
The Yersinia enterocolitica type three secretion chaperone SycO is integrated into the Yop regulatory network and binds to the Yop secretion protein YscM1. BMC Microbiol (2007) 0.82
Identification of novel protein-protein interactions of Yersinia pestis type III secretion system by yeast two hybrid system. PLoS One (2013) 0.81
Interrelationship between type three secretion system and metabolism in pathogenic bacteria. Front Cell Infect Microbiol (2014) 0.79
Cross-talk between type three secretion system and metabolism in Yersinia. J Biol Chem (2009) 0.78
YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection. PLoS One (2017) 0.75
Cell-free Determination of Binary Complexes That Comprise Extended Protein-Protein Interaction Networks of Yersinia pestis. Mol Cell Proteomics (2016) 0.75
Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol (2007) 3.90
Campylobacters as zoonotic pathogens: a food production perspective. Int J Food Microbiol (2007) 3.51
The P1' specificity of tobacco etch virus protease. Biochem Biophys Res Commun (2002) 2.79
The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure (2004) 2.53
Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III. Cell (2006) 2.15
Noncatalytic assembly of ribonuclease III with double-stranded RNA. Structure (2004) 2.04
Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli. Protein Sci (2005) 1.98
Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol (2011) 1.97
Expression and purification of soluble His(6)-tagged TEV protease. Methods Mol Biol (2009) 1.94
Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro. Protein Expr Purif (2004) 1.78
Structural basis for the substrate specificity of tobacco etch virus protease. J Biol Chem (2002) 1.72
Climate variability and campylobacter infection: an international study. Int J Biometeorol (2004) 1.69
Techniques for detecting chytridiomycosis in wild frogs: comparing histology with real-time Taqman PCR. Dis Aquat Organ (2006) 1.61
Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis (2004) 1.53
Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners. Protein Expr Purif (2005) 1.49
Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei. J Med Microbiol (2004) 1.47
A stepwise model for double-stranded RNA processing by ribonuclease III. Mol Microbiol (2007) 1.44
Maltose-binding protein as a solubility enhancer. Methods Mol Biol (2003) 1.40
Similar modes of polypeptide recognition by export chaperones in flagellar biosynthesis and type III secretion. Nat Struct Biol (2003) 1.39
Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers. FEBS Lett (2003) 1.35
Three-dimensional structure of a macromolecular assembly that regulates type III secretion in Yersinia pestis. J Mol Biol (2005) 1.35
The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J Biol Chem (2003) 1.33
Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion. Mol Microbiol (2005) 1.28
Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure (2009) 1.28
Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immunol (2003) 1.27
Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun (2006) 1.27
A generic method for the production of recombinant proteins in Escherichia coli using a dual hexahistidine-maltose-binding protein affinity tag. Methods Mol Biol (2007) 1.26
Structural characterization of the Yersinia pestis type III secretion system needle protein YscF in complex with its heterodimeric chaperone YscE/YscG. J Mol Biol (2008) 1.26
Differential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein. Acta Crystallogr D Biol Crystallogr (2002) 1.25
A generic protocol for the expression and purification of recombinant proteins in Escherichia coli using a combinatorial His6-maltose binding protein fusion tag. Nat Protoc (2007) 1.25
A spring-loaded state of NusG in its functional cycle is suggested by X-ray crystallography and supported by site-directed mutants. Biochemistry (2003) 1.22
Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. Infect Immun (2004) 1.22
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
A pivotal role for reductive methylation in the de novo crystallization of a ternary complex composed of Yersinia pestis virulence factors YopN, SycN and YscB. Acta Crystallogr D Biol Crystallogr (2004) 1.16
Mutational analysis and biochemical characterization of the Burkholderia thailandensis DW503 quorum-sensing network. J Bacteriol (2004) 1.15
Survey protocol for detecting chytridiomycosis in all Australian frog populations. Dis Aquat Organ (2008) 1.15
Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J Mol Biol (2002) 1.14
High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Biochemistry (2003) 1.14
Structure of the Yersinia pestis type III secretion chaperone SycH in complex with a stable fragment of YscM2. Acta Crystallogr D Biol Crystallogr (2004) 1.13
Structure of ERA in complex with the 3' end of 16S rRNA: implications for ribosome biogenesis. Proc Natl Acad Sci U S A (2009) 1.11
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]. J Pharmacol Exp Ther (2009) 1.11
Three-dimensional structure of the type III secretion chaperone SycE from Yersinia pestis. Acta Crystallogr D Biol Crystallogr (2002) 1.10
Atomic-resolution crystal structure of the proteolytic domain of Archaeoglobus fulgidus lon reveals the conformational variability in the active sites of lon proteases. J Mol Biol (2005) 1.09
The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated. PLoS One (2012) 1.08
Atomic resolution structure of the cytoplasmic domain of Yersinia pestis YscU, a regulatory switch involved in type III secretion. Protein Sci (2009) 1.08
Structural basis for the function of stringent starvation protein a as a transcription factor. J Biol Chem (2005) 1.08
Candidate gene and locus analysis of myopia. Mol Vis (2007) 1.08
Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol Cell Proteomics (2008) 1.05
Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry (2009) 1.05
Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs. Virus Res (2003) 1.05
Intermediate states of ribonuclease III in complex with double-stranded RNA. Structure (2005) 1.03
Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PLoS One (2010) 1.03
Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins. J Struct Funct Genomics (2002) 1.03
Processive degradation of nascent polypeptides, triggered by tandem AGA codons, limits the accumulation of recombinant tobacco etch virus protease in Escherichia coli BL21(DE3). Protein Expr Purif (2002) 1.02
Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules. PLoS One (2011) 1.02
Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J Infect Dis (2002) 1.01
RNase III: Genetics and function; structure and mechanism. Annu Rev Genet (2013) 1.01
Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins. Biochem Biophys Res Commun (2007) 1.00
Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis. Expert Rev Anti Infect Ther (2009) 0.99
Crystal structure of the Yersinia pestis GTPase activator YopE. Protein Sci (2002) 0.99
Crystal structure of the AAA+ alpha domain of E. coli Lon protease at 1.9A resolution. J Struct Biol (2004) 0.99
New protein fold revealed by a 1.65 A resolution crystal structure of Francisella tularensis pathogenicity island protein IglC. Protein Sci (2007) 0.98
Evaluation of the effect of syringe surfaces on protein formulations. J Pharm Sci (2011) 0.97
Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells. J Immunol (2004) 0.97
Overproduction, purification and structure determination of human dual-specificity phosphatase 14. Acta Crystallogr D Biol Crystallogr (2009) 0.97
A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice. J Biol Chem (2011) 0.95
Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clin Vaccine Immunol (2007) 0.95
Surveillance for batrachochytrium dendrobatidis using Mixophyes (Anura: Myobatrachidae) larvae. J Wildl Dis (2007) 0.95
Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. J Med Chem (2011) 0.95